6BR5
N2 neuraminidase in complex with a novel antiviral compound
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX1 |
Synchrotron site | Australian Synchrotron |
Beamline | MX1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2017-06-17 |
Detector | ADSC QUANTUM 210r |
Wavelength(s) | 0.979 |
Spacegroup name | P 4 21 2 |
Unit cell lengths | 110.056, 110.056, 70.081 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 38.911 - 2.038 |
R-factor | 0.168872122738 |
Rwork | 0.166 |
R-free | 0.22163 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4gzo |
RMSD bond length | 0.007 |
RMSD bond angle | 0.950 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHENIX |
Refinement software | PHENIX (1.12_2829) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 43.280 | 2.090 |
High resolution limit [Å] | 2.030 | 2.040 |
Rmerge | 0.106 | 0.918 |
Rmeas | 0.110 | 0.953 |
Rpim | 0.029 | 0.253 |
Number of reflections | 28004 | 1919 |
<I/σ(I)> | 20.1 | 3.3 |
Completeness [%] | 99.6 | 95.1 |
Redundancy | 14.4 | 13.6 |
CC(1/2) | 0.933 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 8 | 293 | 0.1M Tris, pH 8.0 20% PEG 400 |